Tag: showdown
-
PhIII data puts AZ one step closer to severe-asthma showdown with GSK – FiercePharma
FiercePharma PhIII data puts AZ one step closer to severe-asthma showdown with GSKFiercePharmaLast week, the British drugmaker announced that its candidate for severe asthma with eosinophilic inflammation–benralizumab–had nailed its primary endpoint in two Phase III studies, beating out placebo at paring down the annual asthma exacerbation … View full post on asthma – Google News
-
AstraZeneca squares off against Roche in blockbuster PhIII asthma showdown – FierceBiotech
Reuters UK AstraZeneca squares off against Roche in blockbuster PhIII asthma showdownFierceBiotechReceptos, meanwhile, in-licensed an IL-13 drug from AbbVie after the pharma company decided to de-prioritize its respiratory efforts, including a program for asthma. Receptos is testing RPC4046 for Eosinophilic esophagitis, an orphan disease, and …AstraZeneca starts final-stage tests on severe asthma drugReutersAstraZeneca share price:…